Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer

NCT00462735 is registered in ClinicalTrials.gov with Johnny Kao as lead sponsor.

NCT NCT00462735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer
Lead sponsor
Johnny Kao
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
October 31, 2010
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the larynx, cancer of the oral cavity, cancer of the pharynx, head and neck cancer, nose neoplasms, paranasal sinus neoplasms